Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis.

Irie, Erika

Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis. [electronic resource] - International journal of hematology Apr 2010 - 501-8 p. digital

Publication Type: Case Reports; Journal Article

1865-3774

10.1007/s12185-010-0528-6 doi


Agammaglobulinemia--drug therapy
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
B-Lymphocytes--drug effects
Bleomycin--administration & dosage
Cell Differentiation--drug effects
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Homeostasis--drug effects
Humans
Immunophenotyping
Lymphoma, Follicular--drug therapy
Middle Aged
Prednisone--administration & dosage
Procarbazine--administration & dosage
Rituximab
Severity of Illness Index
T-Lymphocytes--drug effects
Vincristine--administration & dosage